Author Correction: Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population

Jonathan J Lau^#^{1

2

3}, Samuel M S Cheng^#³, Kathy Leung^{1

2

3

4}, Cheuk Kwong Lee⁵, Asmaa Hachim⁶, Leo C H Tsang³, Kenny W H Yam³, Sara Chaothai³, Kelvin K H Kwan³, Zacary Y H Chai³, Tiffany H K Lo^{1

2

3}, Masashi Mori⁷, Chao Wu⁸, Sophie A Valkenburg^{6

9}, Gaya K Amarasinghe⁸, Eric H Y Lau^{1

2

3}, David S C Hui¹⁰, Gabriel M Leung^{1

2

3}, Malik Peiris^{3

11}, Joseph T Wu^{12

13

14

15}

Affiliations

¹ WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
² Laboratory of Data Discovery for Health (D24H), Hong Kong SAR, China.
³ School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
⁴ The University of Hong Kong - Shenzhen Hospital, Shenzhen, China.
⁵ Hong Kong Red Cross Blood Transfusion Service, Hong Kong SAR, People's Republic of China.
⁶ HKU-Pasteur Research Pole, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
⁷ Research Institute for Bioresources and Biotechnology, Ishikawa Prefectural University, Nonoichi, Japan.
⁸ Department of Pathology and Immunology, Washington University School of Medicine at St. Louis, St. Louis, MO, USA.
⁹ Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia.
¹⁰ Department of Medicine and Therapeutics and Stanley Ho Centre for Emerging Infectious Diseases, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong SAR, China.
¹¹ Centre for Immunology and Infection, Hong Kong SAR, China.
¹² WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China. joewu@hku.hk.
¹³ Laboratory of Data Discovery for Health (D24H), Hong Kong SAR, China. joewu@hku.hk.
¹⁴ School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China. joewu@hku.hk.
¹⁵ The University of Hong Kong - Shenzhen Hospital, Shenzhen, China. joewu@hku.hk.

^# Contributed equally.

PMID: 37875568
PMCID: PMC10803247
DOI: 10.1038/s41591-023-02648-2

Published Erratum

Author Correction: Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population

Jonathan J Lau et al. Nat Med. 2024 Jan.

. 2024 Jan;30(1):305.

doi: 10.1038/s41591-023-02648-2.

Authors

Affiliations

¹ WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
² Laboratory of Data Discovery for Health (D24H), Hong Kong SAR, China.
³ School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
⁴ The University of Hong Kong - Shenzhen Hospital, Shenzhen, China.
⁵ Hong Kong Red Cross Blood Transfusion Service, Hong Kong SAR, People's Republic of China.
⁶ HKU-Pasteur Research Pole, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
⁷ Research Institute for Bioresources and Biotechnology, Ishikawa Prefectural University, Nonoichi, Japan.
⁸ Department of Pathology and Immunology, Washington University School of Medicine at St. Louis, St. Louis, MO, USA.
⁹ Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia.
¹⁰ Department of Medicine and Therapeutics and Stanley Ho Centre for Emerging Infectious Diseases, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong SAR, China.
¹¹ Centre for Immunology and Infection, Hong Kong SAR, China.
¹² WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China. joewu@hku.hk.
¹³ Laboratory of Data Discovery for Health (D24H), Hong Kong SAR, China. joewu@hku.hk.
¹⁴ School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China. joewu@hku.hk.
¹⁵ The University of Hong Kong - Shenzhen Hospital, Shenzhen, China. joewu@hku.hk.

^# Contributed equally.

PMID: 37875568
PMCID: PMC10803247
DOI: 10.1038/s41591-023-02648-2

No abstract available

PubMed Disclaimer

Erratum for

Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population.
Lau JJ, Cheng SMS, Leung K, Lee CK, Hachim A, Tsang LCH, Yam KWH, Chaothai S, Kwan KKH, Chai ZYH, Lo THK, Mori M, Wu C, Valkenburg SA, Amarasinghe GK, Lau EHY, Hui DSC, Leung GM, Peiris M, Wu JT. Lau JJ, et al. Nat Med. 2023 Feb;29(2):348-357. doi: 10.1038/s41591-023-02219-5. Epub 2023 Jan 18. Nat Med. 2023. PMID: 36652990 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Author Correction: Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population

Affiliations

Author Correction: Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population

Authors

Affiliations

Erratum for

Publication types

LinkOut - more resources

Full Text Sources

Miscellaneous